Search of: Boceprevir - List Results

Found 10 studies with search of:

Boceprevir

Hide studies that are not seeking new volunteers.

Display Options

Rank

Status

Study

1

Completed

Comparison of Safety and Resulting Blood Level Profiles After Administration of a New Boceprevir Tablet Versus Its Current Capsule Formulation for Treatment of Chronic Hepatitis C (P06992)(COMPLETED)

Condition:	Hepatitis C
Intervention:	Drug: boceprevir

2

Enrolling by invitation

Boceprevir Treatment in Subjects With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (Study P05514AM1)

Condition:	Hepatitis C, Chronic
Interventions:	Drug: Boceprevir; Biological: Peginterferon alfa-2b (SCH 54031); Drug: Ribavirin (SCH 18908)

3

Recruiting

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM3)

Conditions:	HIV Infections; Hepatitis C; HCV Infection
Interventions:	Drug: PEG2b plus ribavirin followed by placebo; Drug: PEG2b plus ribavirin followed by boceprevir/PEG2b/ribavirin

4

Active, not recruiting

Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM4)

Condition:	Hepatitis C, Chronic
Interventions:	Drug: Boceprevir (SCH 503034); Biological: Peginterferon alfa-2b (SCH 54031); Drug: Ribavirin (SCH 18908); Drug: Boceprevir placebo

5

Completed

Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)

Condition:	Hepatitis C, Chronic
Interventions:	Drug: Boceprevir (SCH 503034); Biological: Peginterferon alfa-2b (SCH 54031); Drug: Ribavirin (SCH 18908); Drug: Boceprevir placebo

6

Active, not recruiting

Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1)

Condition:	Hepatitis C, Chronic
Interventions:	Drug: Boceprevir (SCH 503034); Drug: erythropoietin; Biological: Peginterferon alfa-2b (SCH 54031); Drug: Ribavirin (SCH 18908)

7

Enrolling by invitation

Three-year Follow-up of Subjects After Administration of Boceprevir for the Treatment of Chronic Hepatitis C (Study P05063)

Conditions:	Hepatitis C, Chronic; Hepacivirus
Interventions:	Drug: Boceprevir (SCH 503034); Biological: Peginterferon alfa-2b (SCH 054031); Drug: Ribavirin (SCH 018908); Drug: Placebo

8

Active, not recruiting

Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)

Condition:	Hepatitis C, Chronic
Interventions:	Drug: Boceprevir; Other: Placebo; Biological: Peginterferon alfa-2a; Drug: Ribavirin

9

Completed

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523AM2)(COMPLETED)

Condition:	Chronic Hepatitis C
Interventions:	Drug: SCH 503034 (boceprevir); Drug: peginterferon-alfa 2b; Drug: ribavirin 200 mg capsules in doses of 800 to 1400 mg/day; Drug: ribavirin 200 mg capsules in doses of 400 to 1000 mg/day

10

Completed

SCH 503034 Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659)(COMPLETED)

Condition:	Chronic Hepatitis C
Intervention:	Drug: SCH 503034

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.

RSS Feeds for studies found by your search that were:

First received in the last 14 days,

Last updated (includes received) in the last 30 days

Download Options